Test Price
2,800 AED✅ Home Collection Available
TNFRSF13B Gene Common Variable Immunodeficiency Type 2 Genetic Test | 2800 AED | DHA-Compliant
Executive Summary & Core Metrics
Executive Summary
This NGS-based genetic test targets the TNFRSF13B gene to diagnose Common Variable Immunodeficiency Type 2 (CVID2) with 99.9% diagnostic sensitivity. It provides definitive molecular confirmation for personalized treatment and family counseling.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance with result interpretation by a DHA-licensed genetics expert.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price
2800 AED
DHA-Compliant
TAT: 3–4 Weeks
Sample: Blood / DNA / FTA Card
Test Overview & Methodology
This NGS panel targets the TNFRSF13B gene to diagnose Common Variable Immunodeficiency Type 2 (CVID2), an inherited disorder causing recurrent infections and autoimmune manifestations. The test provides definitive molecular confirmation critical for individualized treatment and family counseling.
| Feature | Our ISO 9001:2015 Test | Closest Alternative |
|---|---|---|
| Precision | High-coverage NGS with variant confirmation | Sanger sequencing (single exon only) |
| Method | Next Generation Sequencing (Illumina platform) | Microarray-based genotyping |
| Speed | 3–4 weeks with clinical interpretation | 6–8 weeks without genetic counseling |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Genetics, I understand the anxiety that accompanies a possible immunodeficiency diagnosis. This test provides molecular clarity that empowers families to make informed decisions. Always correlate results with your clinical history and never stop prescribed medications without direct medical advice.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403
Medication Warning
Do not discontinue prescribed medication (including immunosuppressants or immunoglobulin therapy) without consulting your doctor.
Safety Exclusion Criteria & Red Flags
- Acute febrile illness or active infection requiring hospitalization — postpone testing until resolution.
- Recent blood transfusion (within 4 weeks) — may interfere with germline DNA analysis.
- Inability to provide adequate sample volume or unsuitable specimen (e.g., hemolyzed blood).
- Patients under 18 must have parental consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flag: If you experience severe respiratory distress, sepsis signs, or anaphylaxis, immediately call 998 or visit the nearest ER.
Patient FAQ & Clinical Guidance
1. What does the TNFRSF13B genetic test diagnose?
This test identifies pathogenic variants in TNFRSF13B causing Common Variable Immunodeficiency Type 2, a primary antibody deficiency characterized by recurrent infections and autoimmune features. Clinical correlation with immunoglobulin levels is mandatory for a definitive diagnosis.
2. How should I prepare for the sample collection?
No fasting is required; however, a certified genetic counseling session is mandatory before collection to document family history and obtain informed consent. Our home phlebotomist will collect a blood sample or accept a pre-extracted DNA/FTA card.
3. Can this be used for pediatric patients in the UAE?
Yes, under strict provisions of Federal Decree-Law No. 4 of 2016 on Medical Liability: written parental/guardian consent is required, and a pediatric immunologist must co-sign the request. Our team ensures full compliance with DHA minor data protection regulations.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Compliance: This service strictly adheres to the UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed within ISO 9001:2015 certified facilities (Cert: INT/EGQ/2509DA/3139).
Licensed Facility: DHA Facility License No. 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | TNFRSF13B Gene Common Variable Immunodeficiency Type 2 Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Blood, DNA, FTA Card (VIP Mobile Phlebotomy Available) |
| Methodology Used | Next Generation Sequencing (NGS) on Illumina Platform with Sanger Confirmation |
| ICD-10-CM Code | D83.8, L98.8, Z13.0 |
| LOINC Code | 69568-0 |
| DHA Facility License & Address | License No. 1143, DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians